In June 2015, the FDA revoked the “generally recognized as safe” status of partially hydrogenated oils (PHOs). The FDA gave food manufacturers three years—until June 18, 2018—to remove all PHOs from their products. Because of the potential health risks of eating partially hydrogenated oils, including heart disease and obesity, most […]
The following is a guest post by Alan S. Louie, Ph.D., Research Director at IDC Health Insights. Companies in the life sciences are well along the path to industry transformation in the shadow of blockbuster patent expirations. Changes in the industry have been unusually dramatic and swift, resulting in core […]
For many cancer patients, coping with the consequences of chemotherapy treatment can be as much of a challenge as living with the disease itself. Some potentially useful chemotherapeutic agents are so toxic to healthy cells that they cannot be directly administered to patients. By conjugating these drugs to monoclonal antibodies […]
The issues surrounding psychiatric disorders have long been swept under the rug, but the conversation about mental illness is finally opening up. From classrooms to research labs to the halls of Congress, people are searching for solutions to this public health crisis. Scientists are seeking innovative new treatment options that […]
Times have certainly changed for the gas and oil industry. Long gone are the days of the economic boom fueled by hydraulic fracturing, better known as fracking. Plummeting prices of crude oil have caused global market volatility, resulting in companies having to downsize. This decrease in workforce, combined with the […]
“Personalized medicine” is an increasingly popular catchphrase in modern health care and advocates of this approach argue that doctors should not assume that one treatment will work for every patient with a certain disease or condition. Instead, it’s believed that doctors should prescribe individualized medical treatments based on an evaluation […]
A recent report highlights the ongoing problem of 67% of metal cans containing bisphenol A (BPA), which may have the potential to negatively affect hormonal systems. While there’s no concrete proof that it actually causes harm in humans, many individuals remain concerned that the chemical can transfer from the container to the food, and then from the food into the human body. Faced with mounting pressures, CPG firms have been investigating BPA alternatives for their food packaging.
Imagine if there were a simple blood test for cancer. What if that test could determine the severity of the disease and predict patient outcomes? These musings have challenged researchers in the field of cancer immunomics for decades. Since the 1970’s, scientists have studied cancer biomarkers, hoping to design diagnostic […]
Today’s shifting regulatory environment continues to exert mounting pressure upon the pharmaceutical industry. In a recent meeting with Congress, the FDA presented draft guidance seeking to modernize drug manufacturing. The suggestions encourage life sciences firms to adopt emerging technologies to improve drug quality. Poor quality can lead to costly recalls stemming from a variety of failures such as compromised sterility, mold in manufacturing areas and contaminated containers. It can even result in delayed product launches. In addition to the potential health risks, these delays and recalls contribute to shortages, which can prevent life-saving drugs from reaching the patients who need them.
In today’s globalized world, emerging markets are playing an increasingly important role. Emerging markets are countries that are right on the edge of becoming developed markets. Traditionally, the term was used to describe the four BRIC countries—Brazil, Russia, India and China—but as economic conditions in Latin America and the Asia-Pacific […]